Plain-English translation of NCT05663242 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial compares two common anesthesia medicines — and — used during lung cancer surgery to see if one leads to better long-term outcomes than the other. Researchers want to understand not just how well patients recover from surgery, but also how the choice of anesthesia might affect cancer progression and survival over time.
Doctors use different anesthesia medicines every day, but it's unclear whether the choice of medication might influence how well patients do after lung cancer surgery — both in terms of immediate recovery and long-term cancer outcomes. This trial aims to fill that gap by carefully tracking how each medicine affects patient survival and quality of life.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive one of two anesthesia medicines during your scheduled lung cancer surgery — the choice is made by computer, not by you or your doctor. Your medical team will closely monitor your vital signs and pain control during surgery using the same safety standards for both groups. After surgery, researchers will track your recovery, any complications within 30 days, and your overall health and cancer status at 6 months, 1 year, and 3 years.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Taiwan